Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation

被引:29
|
作者
Gama, Clarissa Severino [1 ,2 ,3 ,4 ]
Berk, Michael [3 ,5 ,6 ]
Andreazza, Ana Cristina [1 ,2 ,7 ]
Kapczinski, Flavio [1 ,2 ,7 ]
Belmonte-de-Abreu, Paulo [1 ,2 ,4 ]
机构
[1] Hosp Clin Porto Alegre, Res Ctr, Mol Psychiat Lab, BR-90035003 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Grad Program Med Psychiat, Porto Alegre, RS, Brazil
[3] Univ Melbourne, Dept Clin & Biomed Sci, Geelong, Vic, Australia
[4] Hosp Clin Porto Alegre, Schizophrenia Program, BR-90035003 Porto Alegre, RS, Brazil
[5] Orygen Res Ctr, Parkville, Vic, Australia
[6] Mental Hlth Res Inst, Parkville, Vic, Australia
[7] Hosp Clin Porto Alegre, Bipolar Disorders Program, BR-90035003 Porto Alegre, RS, Brazil
关键词
Schizophrenia; Brain-derived neurotrophic factor; Superoxide dismutase; Thiobarbituric acid reactive substances; Nerve growth factors;
D O I
10.1590/S1516-44462008000400006
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The neurotrophins, antioxidant enzymes and oxidative markers have reciprocal interactions. This report verified in chronically stable medicated schizophrenic patients whether there are correlations between the serum levels of superoxide dismutase, a key enzyme in the antioxidant defense, thiobarbituric acid reactive substances, a direct index of lipid peroxidation, and brain-derived neurotrophic factor, the most widely distributed neurotrophin. Method: Sixty DSM-IV schizophrenic patients were included (43 males, 17 females). Mean age was 34.7 +/- 10.8 years, mean age at first episode was 19.8 +/- 7.9 years, and mean illness duration was 14.9 +/- 8.5 years. Each subject had a blood sample collected for the determination of serum levels of brain-derived neurotrophic factor, thiobarbituric acid reactive substances and superoxide dismutase. Results: Brain-derived neurotrophic factor levels showed a positive correlation with thiobarbituric acid reactive substances levels (r = 0.333, p = 0.009). Brain-derived neurotrophic factor levels were not correlated with superoxide dismutase levels (r = - 0.181, p = 0.166), and superoxide dismutase levels were not correlated with thiobarbituric acid reactive substances levels (r = 0.141, p = 0.284). Conclusions: The positive correlation between brain-derived neurotrophic factor and thiobarbituric acid reactive substances suggests the need of further investigation on intracellular interactions of neurotrophins, antioxidant enzymes and oxidative markers. In addition, this opens a venue for investigation on treatments for the prevention of neurotoxicity along the course of schizophrenia.
引用
收藏
页码:337 / 340
页数:4
相关论文
共 50 条
  • [1] Brain-derived Neurotrophic Factor and Thiobarbituric Acid Reactive Substances Serum Levels in Chronicaly Medicated Schizophrenic Patients: A Positive Correlation
    Fernandes, Brisa
    Berk, Michael
    Andreazza, Ana Cristina
    Kapczinski, Flavio
    Belmonte-de-Abreu, Paulo
    Gama, Clarissa
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 206S - 206S
  • [2] Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients
    Toyooka, K
    Asama, K
    Watanabe, Y
    Muratake, T
    Takahashi, M
    Someya, T
    Nawa, H
    PSYCHIATRY RESEARCH, 2002, 110 (03) : 249 - 257
  • [3] BDNF (brain-derived neurotrophic factor) serum levels in schizophrenic patients with cognitive deficits
    Utami, N.
    Effendy, E.
    Amin, M. M.
    1ST INT CONF ON TROP MED & INFECT DIS FAC OF MED UNIV SUMATERA UTARA IN CONJUNCTION WITH THE 23RD NATL CONGRESS OF THE INDONESIAN SOC OF TROP & INFECT DIS CONSULTANT AND THE 18TH ANNUAL MEETING OF INTERNAL MED DEPT FAC OF MED UNIV SUMATERA UTARA, 2018, 125
  • [4] Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia
    Yang, Yan Qiu
    Sun, Shilong
    Yu, Ya Qin
    Li, Wen Jun
    Zhang, Xuan
    Xiu, Mei Hong
    Chen, Da Chun
    Yang, Fu De
    Liu, Haibo
    Li, Cunbo
    Kosten, Thomas R.
    Zhang, Xiang Yang
    NEUROSCIENCE LETTERS, 2011, 502 (01) : 37 - 40
  • [5] Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome
    Akyol, Esra Soydas
    Albayrak, Yakup
    Beyazyuz, Murat
    Aksoy, Nurkan
    Kuloglu, Murat
    Hashimoto, Kenji
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 865 - 872
  • [6] Effects of haloperidol on serum brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients
    Liu, P
    Tang, SW
    Chen, EYH
    Helmeste, DM
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 57 - 57
  • [7] Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Schizophrenic Patients with Depressive Sypmptoms: A Preliminary Study
    Esen-Danaci, Aysen
    Aydemir, Oemer
    Deveci, Artuner
    Taneli, Fatma
    Taskin, Oryal
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 (03): : 236 - 240
  • [8] Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: A positive correlation
    Pedrini, Mariana
    Chendo, Ines
    Grande, Iria
    Lobato, Maria Ines
    Belmonte-de-Abreu, Paulo Silva
    Lersch, Camila
    Walz, Julio
    Kauer-Sant'Anna, Marcia
    Kapczinski, Flavio
    Gama, Clarissa Severino
    NEUROSCIENCE LETTERS, 2011, 491 (03) : 207 - 210
  • [9] A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia
    Niitsu, Tomihisa
    Ishima, Tamaki
    Yoshida, Taisuke
    Hashimoto, Tasuku
    Matsuzawa, Daisuke
    Shirayama, Yukihiko
    Nakazato, Michiko
    Shimizu, Eiji
    Hashimoto, Kenji
    Iyo, Masaomi
    PSYCHIATRY RESEARCH, 2014, 215 (02) : 268 - 273
  • [10] Levels of Serum Brain-Derived Neurotrophic Factor in Schizophrenia
    Lee, Jimmy
    Nurjono, Milawaty
    Lee, Tih-Shih
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2016, 204 (08) : 636 - 639